These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19519422)

  • 1. Application of high hydrostatic pressure to dissociate aggregates and refold proteins.
    Seefeldt MB; Rosendahl MS; Cleland JL; Hesterberg LK
    Curr Pharm Biotechnol; 2009 Jun; 10(4):447-55. PubMed ID: 19519422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of protein aggregation.
    Philo JS; Arakawa T
    Curr Pharm Biotechnol; 2009 Jun; 10(4):348-51. PubMed ID: 19519409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of protein aggregation by L-arginine.
    Lange C; Rudolph R
    Curr Pharm Biotechnol; 2009 Jun; 10(4):408-14. PubMed ID: 19519416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregation detection and removal biopharmaceutical proteins.
    Gagnon P; Arakawa T
    Curr Pharm Biotechnol; 2009 Jun; 10(4):347. PubMed ID: 19519408
    [No Abstract]   [Full Text] [Related]  

  • 5. Ion exchange chromatography of proteins and clearance of aggregates.
    Yigzaw Y; Hinckley P; Hewig A; Vedantham G
    Curr Pharm Biotechnol; 2009 Jun; 10(4):421-6. PubMed ID: 19519418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. To be excluded or to bind, that is the question: Arginine effects on proteins.
    Nakakido M; Kudou M; Arakawa T; Tsumoto K
    Curr Pharm Biotechnol; 2009 Jun; 10(4):415-20. PubMed ID: 19519417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stress-free chromatography: affinity chromatography.
    Arakawa T; Kita Y; Sato H; Ejima D
    Curr Pharm Biotechnol; 2009 Jun; 10(4):456-60. PubMed ID: 19519423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of additives on protein aggregation.
    Hamada H; Arakawa T; Shiraki K
    Curr Pharm Biotechnol; 2009 Jun; 10(4):400-7. PubMed ID: 19519415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of vibrational spectroscopy to the structural characterization of monoclonal antibody and its aggregate.
    Li CH; Li T
    Curr Pharm Biotechnol; 2009 Jun; 10(4):391-9. PubMed ID: 19519414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-free chromatography: IEC and HIC.
    Arakawa T; Kita Y; Ejima D
    Curr Pharm Biotechnol; 2009 Jun; 10(4):461-3. PubMed ID: 19519424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody aggregate removal by hydroxyapatite chromatography.
    Gagnon P; Beam K
    Curr Pharm Biotechnol; 2009 Jun; 10(4):440-6. PubMed ID: 19519421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation and characterization of protein aggregates and particles by field flow fractionation.
    Cao S; Pollastrini J; Jiang Y
    Curr Pharm Biotechnol; 2009 Jun; 10(4):382-90. PubMed ID: 19519413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG aggregate removal by charged-hydrophobic mixed mode chromatography.
    Gagnon P
    Curr Pharm Biotechnol; 2009 Jun; 10(4):434-9. PubMed ID: 19519420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advancement in application of hydrophobic interaction chromatography for aggregate removal in industrial purification process.
    Lu Y; Williamson B; Gillespie R
    Curr Pharm Biotechnol; 2009 Jun; 10(4):427-33. PubMed ID: 19519419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical review of methods for size characterization of non-particulate protein aggregates.
    Philo JS
    Curr Pharm Biotechnol; 2009 Jun; 10(4):359-72. PubMed ID: 19519411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of analytical methods for subvisible and visible particles.
    Narhi LO; Jiang Y; Cao S; Benedek K; Shnek D
    Curr Pharm Biotechnol; 2009 Jun; 10(4):373-81. PubMed ID: 19519412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The high pH and pH-shift refolding technology.
    Lin X; Umetsu T
    Curr Pharm Biotechnol; 2010 Apr; 11(3):293-9. PubMed ID: 20210740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous two-phase systems: A viable platform in the manufacturing of biopharmaceuticals.
    Rosa PA; Ferreira IF; Azevedo AM; Aires-Barros MR
    J Chromatogr A; 2010 Apr; 1217(16):2296-305. PubMed ID: 19962707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggregates in monoclonal antibody manufacturing processes.
    Vázquez-Rey M; Lang DA
    Biotechnol Bioeng; 2011 Jul; 108(7):1494-508. PubMed ID: 21480193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High hydrostatic pressure can reverse aggregation of protein folding intermediates and facilitate acquisition of native structure.
    Gorovits BM; Horowitz PM
    Biochemistry; 1998 Apr; 37(17):6132-5. PubMed ID: 9558352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.